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INTRODUCTION
Teeth have several important functions such as 
mastication and speech (1). Dental caries affects patients, 
especially young children, so often causing significant 
loss of tooth structure (2,3). Streptococcus mutans, is an 
important microorganism in the production of acid in the 
dental plaque (4,5). The reduction of bacteria associated 
with caries in the dental plaque is a major preventive 
strategy and is also used as treatment resource (6). 
Chlorhexidine has been used for decades as an 
antimicrobial agent in dentistry because it reduces the 
number of certain microorganisms (2,4). However, its 
use should be restricted to a few days due to various 
side effects (7-9), and thus a substance with no collateral 
effects has been sought (10). Copaiba oil has been used 
for various purposes in traditional medicine therapies 
in Brazil (11,12). Many of its properties, such as its 
antibacterial action, have been studied to include this 
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phytotherapic agent as an option for the treatment of 
infections (13,14).
The aim of this study was to evaluate the minimum 
inhibitory concentration (MIC) and the minimum 
bactericidal concentration (MBC) of copaiba oil against 
the cariogenic microorganism S. mutans.
MATERIAL AND METHODS
Three solutions were used. The negative control 
solution was prepared with 30 mL of alcohol 96°, 20 
mL of propylene glycol, 20 mL of polyethylene glycol, 
20 mL of glycerin and 10 mL of distilled water. The test 
solution consisted of negative control solution replacing 
distilled water by the same amount of copaiba oil. For the 
positive control solution, chlorhexidine was added to the 
negative control solution to reach a final concentration 
of 0.12%. The microorganism used was a standard strain 
of S. mutans (ATCC 25175; American Type Culture 
Correspondence: Profa. Dra. Maria Aparecida Scatamburlo Moreira, Avenida Peter Henry Rolfs, s/n, Campus Universitário, 36570-000 Viçosa, MG, 
Brasil. Tel: +55-31-3899-1457. e-mail: masm@ufv.br
ISSN 0103-6440Braz Dent J (2012) 23(1): 36-38
Braz Dent J 23(1) 2012
Bacteriostatic effect of copaiba oil 37
Collection, Manassas, VA, USA). 
The MICs of the solutions against S. mutans were 
obtained as follows. Using the method of successive 
dilutions of solutions in liquid culture medium (15), 
the MICs were prepared with a series of 9 culture 
tubes containing brain hearth infusion (BHI) (Oxoid, 
Hampshire, UK) broth contaminated by S. mutans 
suspension in saline, adjusted to McFarland standard tube 
#1. The first 8 tubes of each series contained decreasing 
concentrations of one of the solutions (100 µL/mL to 
0.78 µL/mL) and the 9th tube had the control of bacterial 
growth without solution. The tubes were incubated 
at 35.5°C for 48 h, and the inhibition was analyzed 
visually, recognizing the microbial growth by turbidity 
of the medium. The MIC was considered as the lowest 
concentration of the solution required to inhibit microbial 
growth without turbidity of the medium compared with 
a negative control without bacterial contamination.
The MBCs of the solutions against S. mutans were 
obtained as follows. For all tubes where the bacterium was 
inhibited in the MIC assay, using the method described by 
Phillipps (16), 0.1 mL aliquots of the contents were added 
to Petri dishes with 30 mL of BHI agar and incubated 
at 35.5°C for 24 h. The dishes were analyzed visually 
to obtain the MBC, which was the highest dilution that 
killed 99.9% of bacteria, showing no growth on the Petri 
dish. All tests were performed in triplicate.
RESULTS
Regarding the MIC of solutions against S. mutans, 
the copaiba oil showed antimicrobial action against the 
bacterial strain at all tested concentrations, as indicated 
by the inhibition of growth and turbidity of the medium 
in all tubes. The MIC obtained in this test was 0.78 µL/
mL of solution in the culture medium. For the tubes with 
different concentrations of 0.12% chlorhexidine solution, 
inhibition of growth was observed in the first five tubes 
and the MIC obtained in this test was 6.25 µL/mL of 
solution in the culture medium. For other concentrations, 
microbial growth was identified by turbidity of the 
medium. The negative control solution had no inhibitory 
activity against S. mutans in the concentrations used. 
Regarding the MBC of the solutions against S. 
mutans, all the dishes showed microbial growth after 
24 h, with no bactericidal action of any concentration 
of solutions against S. mutans. This indicates that the 
antimicrobial activity reported in the MIC test was 
bacteriostatic for both the copaiba oil and the positive 
control. The inoculum used for MIC was obtained by 
counting of viable bacteria in the Petri dishes, and the 
result was 1.6 x 106 colony forming units.
DISCUSSION
The antimicrobial activity of the copaiba oil was 
demonstrated in the MIC test, as this solution interfered 
with the microbial growth at all tested concentrations. 
This antimicrobial activity has been described by Pieri 
et al. (13) against other oral microorganisms such as S. 
pyogenes and S. salivarius. Copaiba oil has advantages 
over chlorhexidine because it is composed by several 
different substances that may have different interactions 
with the bacterial cell, reducing the development of 
resistant S. mutans strains. This justifies the use of 
only the ATCC strain in the present study, as field 
isolates are expected to have similar susceptibility to 
the antimicrobial effect of the Copaiba oil compared to 
the stardard strain. 
This inhibition, however, seems to be bacteriostatic 
in nature, as none of the concentrations caused 99.9% of 
bacterial destruction in the MBC test. According Souza 
et al. (17), this bacteriostatic activity may be attributed 
to the copalic acid, a component of this oil. Packer and 
Luz (18) did not find microbial inhibition by copaiba oil 
against other bacterial strains as Staphylococcus aureus 
and Pseudomonas aeruginosa, with some strains having 
resistance to the oil’s components.
Bacteriostatic activity of 0.12% chlorhexidine 
solution was found at concentrations between 100 and 
6.75 µL/mL. Swerts et al. (19) obtained similar results 
but also found inhibitory activity at lower chlorhexidine 
concentration.
The findings of the present study suggest that the 
copaiba oil has great potential for use against the growth 
of S. mutans, the main etiological agent of dental caries. 
In addition, even at low concentration, the copaiba oil 
was as effective as 0.12% chlorhexidine against this 
pathogen. However, further studies should be done 
involving analysis of the ideal concentration in the use 
of copaiba oil and the possible collateral effects of this 
phytotherapic agent in long-term treatment.
RESUMO
Este estudo avaliou a atividade inibitória do óleo de copaíba 
(Copaifera officinalis) contra o microrganismo cariogênico, 
Streptococcus mutans. Para isso, foi realizado um teste de 
concentração mínima inibitória do óleo de copaíba contra S. 
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mutans, utilizando a técnica de diluição seriada em caldo, com 
um controle negativo, um controle positivo (clorexidina a 0,12%) 
e uma solução de óleo de copaíba 10% como teste. Também 
foi conduzido um teste de concentração mínima bactericida 
com os tubos que apresentaram inibição microbiana. No teste 
de concentração inibitória mínima, o óleo de copaíba mostrou 
inibição do crescimento bacteriano em todas as concentrações 
testadas até 0,78 μL/mL da solução a 10% do óleo de copaíba no 
caldo. Além disso, o controle negativo não teve nenhuma inibição, 
e a solução de clorexidina 0,12% foi eficaz até 6,25 μL/mL no 
caldo. O óleo de copaíba mostrou uma atividade bacteriostática 
contra  S. mutans em baixas concentrações, apresentando-se assim 
como uma opção de fitoterápico a ser utilizado contra bactérias 
cariogênicas na prevenção de cáries.
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